D L Carlson Investment Group Inc Abbott Laboratories Transaction History

D L Carlson Investment Group Inc

$541 Million
Q3 2024

A detailed history of D L Carlson Investment Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, D L Carlson Investment Group Inc holds 2,348 shares of ABT stock, worth $277,369. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,348

Previous 2,777 15.45%

Holding current value

$277,369

Previous $288,000 7.29%

% of portfolio

0.05%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $42,930 - $50,677	-429 Reduced 15.45%	2,348 $267,000
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $805 - $899	-8 Reduced 0.29%	2,777 $288,000
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $5,366 - $5,927	-49 Reduced 1.73%	2,785 $316,000
Q4 2023 Feb 16, 2024	SELL	$90.19 - $110.4 $16,685 - $20,424	-185 Reduced 6.13%	2,834 $311,000
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $6,349 - $7,074	63 Added 2.13%	3,019 $329,000
Q1 2023 May 17, 2023	BUY	$96.86 - $114.01 $26,539 - $31,238	274 Added 10.22%	2,956 $299,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $6,844 - $8,029	-72 Reduced 2.61%	2,682 $294,000
Q3 2022 Nov 18, 2022	BUY	$96.76 - $112.03 $14,514 - $16,804	150 Added 5.76%	2,754 $266,000
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $28,505 - $34,760	-250 Reduced 8.76%	2,604 $308,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $42,347 - $46,848	-363 Reduced 11.28%	2,854 $337,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $10,579 - $12,453	-100 Reduced 3.01%	3,217 $373,000
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $211,890 - $230,899	-2,018 Reduced 37.83%	3,317 $363,000
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $92,649 - $118,580	-1,210 Reduced 18.49%	5,335 $488,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $71,928 - $105,179	-1,145 Reduced 14.89%	6,545 $516,000
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $124,045 - $138,092	-1,580 Reduced 17.04%	7,690 $668,000
Q3 2019 Nov 05, 2019	SELL	$81.84 - $88.74 $47,058 - $51,025	-575 Reduced 5.84%	9,270 $776,000
Q2 2019 Aug 19, 2019	SELL	$72.88 - $85.0 $1.21 Million - $1.41 Million	-16,575 Reduced 62.74%	9,845 $828,000
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $72,842 - $88,066	-1,100 Reduced 4.0%	26,420 $2.11 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $8,878 - $10,710	-146 Reduced 0.53%	27,520 $2.02 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $15,543 - $17,155	270 Added 0.99%	27,666 $1.69 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $157,556 - $178,136	-2,800 Reduced 9.27%	27,396 $1.64 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.45 Million - $1.62 Million	30,196	30,196 $1.61 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on D L Carlson Investment Group Inc with notifications on news.

Account

D L Carlson Investment Group Inc Abbott Laboratories Transaction History